Acinetobacter baumannii (A. baumannii) is undoubtedly one of the most successful
pathogens in the modern healthcare system. With invasive procedures, antibiotic use and …

During the last decade, the efforts to combat multidrugresistant (MDR) microorganisms
mainly focused on gram-positive bacteria, namely, methicillin-resistant Staphylococcus …

International and local surveillance networks as well as numerous reports in the biomedical
literature provide evidence that the prevalence of antibiotic resistant Gram-negative bacteria …

An understanding of the epidemiology of multi-drug-resistant (MDR) Acinetobacter
baumannii and Pseudomonas aeruginosa infections is necessary in order to develop …

The survival rates for burn patients have improved substantially in the past few decades due
to advances in modern medical care in specialized burn centers. Burn wound infections are …

A retrospective case–control study was performed to assess risk factors and the clinical and
economic consequences associated with acquisition of carbapenem-resistant Acinetobacter …

Survival after burn has steadily improved over the last few decades. Patient mortality is,
however, still the primary outcome measure for burn care. Scoring systems aim to use the …

OBJECTIVE: To review and evaluate clinically relevant epidemiology, microbiology, and
clinical studies regarding the treatment of multidrug-resistant Acinetobacter infections. DATA …

BACKGROUND: Risk factors and outcome in patients who acquire nosocomial infections
due to carbapenem-resistant Acinetobacter baumannii (CRAB) are rarely investigated …

Acinetobacter baumannii is an extracellular opportunistic human pathogen that is becoming
increasingly problematic in hospitals. In the present study, we demonstrate that the A …